Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2022-10-12 Proxy Solicitation & In…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
Circular
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular issued by Yankuang Energy Group Company Limited concerning several transactions: an absorption and merger, and continuing connected transactions related to financial services. It includes detailed definitions, letters from the board, independent financial adviser, valuation reports, and other appendices. The document is lengthy (15,000 characters) and contains comprehensive information about the transactions, including financial and valuation details. It is not a simple announcement or notice but a detailed circular typically sent to shareholders to inform them about significant corporate actions requiring their approval. This type of document aligns with a Proxy Solicitation & Information Statement (PSI), which provides information to shareholders to solicit their votes for meetings, especially extraordinary general meetings (EGMs) involving major transactions and connected party dealings. The presence of a proxy form, detailed transaction descriptions, and independent adviser letters further supports this classification. Therefore, the document is best classified as a Proxy Solicitation & Information Statement (PSI).
2022-10-12 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return for movements in securities, specifically focusing on share capital, issued shares, share options, and confirmations related to securities issued by the issuer CStone Pharmaceuticals. It includes data on authorized and issued shares, share option schemes, and confirmations by a director. The document is submitted to the Hong Kong Exchanges and Clearing Limited and references compliance with listing rules. It is not a full financial report, earnings release, or management discussion, but rather a regulatory filing reporting share capital movements and confirmations. The document length is over 10,000 characters and contains substantive data, not just an announcement or certification. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance documents that do not fit other specific categories.
2022-10-07 English
Form of Proxy for Use at the 2022 Second Extraordinary General Meeting to be Held on Friday, 28 October 2022
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form of Proxy for use at the 2022 Second Extraordinary General Meeting (EGM) of Yankuang Energy Group Company Limited. It includes instructions for shareholders to appoint proxies to vote on resolutions at the EGM. The content is procedural and related to voting arrangements for a shareholder meeting, not the meeting materials themselves or the results of the vote. It is not a report or announcement of voting results, nor is it a management or financial report. Proxy forms are typically classified under Proxy Solicitation & Information Statement filings, as they are materials sent to shareholders to provide information and request votes for meetings.
2022-10-05 English
NOTICE OF 2022 SECOND EXTRAORDINARY GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for Yankuang Energy Group Company Limited. It includes details about the meeting date, location, agenda items (such as approval of transactions and agreements), eligibility to attend, proxy instructions, and closure of the register of members. There are no financial statements, management discussion, or detailed financial data presented. The document serves as an announcement to shareholders about the upcoming EGM and the resolutions to be considered. Therefore, it fits the category of a meeting notice rather than a report or results announcement.
2022-10-05 English
NOTIFICATION LETTER
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notification letter dated 5 October 2022 from Yankuang Energy Group Company Limited to shareholders. It announces the publication of the notice and proxy form for the 2022 Second Extraordinary General Meeting (EGM). The letter provides information on how shareholders can access the corporate communications, including the notice and proxy form, either online or in printed form. It also includes a change request form for shareholders to update their preferences for receiving future corporate communications. The document does not contain any financial statements, audit reports, management discussions, or detailed financial data. Instead, it serves as a notification about the availability of meeting materials and proxy forms. According to the classification rules, such a document is an announcement regarding the publication of meeting materials and proxy forms, which fits the category of Proxy Solicitation & Information Statement (PSI). However, since this document is primarily a notification of publication and includes a proxy form, it aligns best with Proxy Solicitation & Information Statement (PSI). The document is not the actual proxy statement or meeting notice itself but a notification letter about their publication and availability. Given the length (9034 characters) and content, it is not a brief announcement but a detailed notification letter with a form. Therefore, the most appropriate classification is Proxy Solicitation & Information Statement (PSI).
2022-10-05 English
Monthly Returns
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 September 2022. It details movements in authorised/registered share capital, issued shares, share options, and confirms no new securities were issued during the month. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance movements. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to share capital movements and confirmations under listing rules. The document is about share capital and share issuance movements but does not announce new share issues or capital changes itself, nor is it a proxy or voting result. It fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document that does not fit other specific categories.
2022-10-05 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.